Where can I learn more about this study?
You can find more information about this study on the websites listed below. When a full report
of the study results is available, it also can be found here.
X www.clinicaltrials.gov Once you are on the website, type “NCT03756285”
into the search box and click “Search”.
X http://www.clinicaltrialsregister.eu Once you are on the website, click “Home and
Search”, then type “2018-002895-42” in the search box and click “Search”.
X www.AstraZenecaClinicalTrials.com Once you are on the website, type “D6580C00003”
into the search box, and click “Find a Study”.
Full Study Title: A Randomized, Double Blind, Placebo-controlled, Parallel Group, Multicentre,
Phase 2a Study to Assess Target Engagement, Safety and Tolerability of AZD4831 in Patients
with Heart Failure with Preserved Ejection Fraction (HFpEF)
AstraZeneca Protocol Number: D6580C00003
National Clinical Trials Number: NCT03756285
EudraCT Number: 2018-002895-42
AstraZeneca sponsored this study and has its headquarters at Cambridge, UK.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part in clinical
research around the world. They help researchers answer important health questions
and find medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on
educating and informing the public about clinical research participation. CISCRP is not involved in recruiting participants
for clinical studies, nor is it involved in conducting clinical studies.
CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org
Version 1.0 2021_08_27
12 | Clinical Study Results